[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337188-105":59,"doc-detail-337188-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bee-pollen-as-a-source-of-biopharmaceuticals-for-neurodegeneration-and-cancer-research-a-scoping-review-and-translational-prospects","Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research - A Scoping Review and Translational Prospects","","Bee Pollen (BP) offers multitargeting bioactive potential that may support management of challenging illnesses, particularly cancer and neurodegeneration. Using scoping review methodology, the review identifies crucial BP-linked bioactivities known for individual BP compounds but largely untapped across the broader BP “bee cocktail”. The synthesis highlights recent findings on compounds that modulate neurodegeneration and cancer pathophysiology, while emphasizing limited studied BP diversity and constraints on translation to clinical use. Key barriers include limited bioavailability, chemical variability and lack of standardization, and difficulties in achieving selective targeting within pathological mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bee-pollen-as-a-source-of-biopharmaceuticals-for-neurodegeneration-and-cancer-research-a-scoping-review-and-translational-prospects/337188/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bee-pollen-as-a-source-of-biopharmaceuticals-for-neurodegeneration-and-cancer-research-a-scoping-review-and-translational-prospects/337188.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the scoping review?","Question",{"text":112,"@type":113},"The review focuses on bee pollen as a source of biopharmaceuticals and its potential roles in neurodegeneration and cancer research, including translational prospects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which methods are used to evaluate evidence in the document?",{"text":117,"@type":113},"The document adopts scoping review methodology to map and identify key bioactivities reported for bee pollen compounds.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges may limit clinical translation of bee pollen findings?",{"text":121,"@type":113},"Clinical progress is described as impeded by limited bioavailability, diversity and lack of phytochemical standardization, and difficulty in selective targeting in some pathological mechanisms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337188,1790465499,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":29,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Review  \nBee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects  \nRachid Kacemi 1 and Maria G. Campos 1,2, *  \nCitation: Kacemi, R.; Campos, M.G. Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects. Molecules 2024, 29, 5893. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/molecules29245893](10.3390/molecules29245893)  \nAcademic Editor: Juraj Majtan  \nReceived: 24 September 2024  \nRevised: 18 November 2024  \nAccepted: 20 November 2024  \nPublished: 13 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Observatory of Drug-Herb Interactions, Faculty of Pharmacy, Heath Sciences Campus, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; [kacemi@gmail.com](kacemi@gmail.com)  \n2 Coimbra Chemistry Centre (CQC, FCT Unit 313) (FCTUC), University of Coimbra, Rua Larga, 3004-531 Coimbra, Portugal  \n* [Correspondence: mgcampos@ff.uc.pt](Correspondence: mgcampos@ff.uc.pt); Tel.: +351-239-488-400  \nAbstract: Bee Pollen (BP) has many advantageous properties relying on its multitargeting potential, a new tendency in managing many challenging illnesses. In cancer and neurodegeneration, the multiple effects of BP could be of unequaled importance and need further investigation. Although still limited, available data interestingly spotlights some floral sources with promising activities in line with this investigation. Adopting scoping review methodology, we have identified many crucial bioactivities that are widely recognized to individual BP compounds but remain completely untapped in this valuable bee cocktail. A wide range of these compounds have been recently found to be endowed with great potential in modulating pivotal processes in neurodegeneration and cancer pathophysiology. In addition, some ubiquitous BP compounds have only been recently isolated, while the number of studied BPs remains extremely limited compared to the endless pool of plant species worldwide. We have also elucidated that clinical profits from these promising perspectives are still impeded by challenging hurdles such as limited bioavailability of the studied phytocompounds, diversity and lack of phytochemical standardization of BP, and the difficulty of selective targeting in some pathophysiological mechanisms. We finally present interesting insights to guide future research and pave the way for urgently needed and simplified clinical investigations.  \nKeywords: aging; apoptosis; autophagy; bee pollen; cancer; epigenetics; ferroptosis; human microbiota; inflammation; neurodegeneration; oxidative stress; polyphenols  \n1. Introduction  \nPharmaceutical drug discovery is facing an overwhelming challenge in many areas of human medicine. Cancer, for example, continues to be one of the most challenging health burdens worldwide. In 2022, there were close to 20 million new diagnosed cases along with 9.7 million deaths from cancer [1] . Neurodegenerative diseases (NDD) are another example of global challenges where disease-modifying therapies are still desperately lacking. This kind of disorders are currently the leading cause of disability and the second foremost cause of death worldwide [2] . Dementia, the obvious manifestation of neurodegeneration, is developing at a frightening pace in the absence of any concrete disease-modifying treatments. While the percentage of aged persons (>60 years) will exceed 21% in 2050 compared to 10% in 2010 [3], the World Health Organization estimates that there are 50 million dementia cases currently in the world with an annua","cbCaiu6grqhzfZWZ","https://ap.wps.com/l/cbCaiu6grqhzfZWZ","pdf",3972155,55,"English","# Abstract\n# Keywords\n# Introduction\n## Global health burden and unmet needs\n## Bioprospection and natural product opportunity\n## Bee pollen as a multidirective natural source","[{\"question\":\"What is the main focus of the scoping review?\",\"answer\":\"The review focuses on bee pollen as a source of biopharmaceuticals and its potential roles in neurodegeneration and cancer research, including translational prospects.\"},{\"question\":\"Which methods are used to evaluate evidence in the document?\",\"answer\":\"The document adopts scoping review methodology to map and identify key bioactivities reported for bee pollen compounds.\"},{\"question\":\"What challenges may limit clinical translation of bee pollen findings?\",\"answer\":\"Clinical progress is described as impeded by limited bioavailability, diversity and lack of phytochemical standardization, and difficulty in selective targeting in some pathological mechanisms.\"}]","Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research - A Scoping Review and Translational Prospects | PDF",1790018058,139,[147,151,155,159,163,166],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db12cb601189fdf33ee3ca5b20d8e530.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2013643a650aa7051678fae79bdfe76.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9485b2338541b854abf27279035e7f2.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6c5231a292114f55043db307da96b09.webp",980,692,{"page_no":24,"url":164,"width":165,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d57ee679dca895713e834a317fcb541.webp",979,{"page_no":29,"url":167,"width":168,"height":169},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9709a468232fe7d5d40801d6e647161d.webp",978,691]